Loading…

A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations

The widening gap between organ availability and need is resulting in a worldwide crisis, particularly concerning kidney transplantation. Regenerative medicine options are becoming increasingly advanced and are taking advantage of progress in novel manufacturing techniques, including 3D bioprinting,...

Full description

Saved in:
Bibliographic Details
Main Authors: Nick Wragg, Liam Burke, Sammy Wilson
Format: Default Article
Published: 2019
Subjects:
Online Access:https://hdl.handle.net/2134/37750
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1822176633051676672
author Nick Wragg
Liam Burke
Sammy Wilson
author_facet Nick Wragg
Liam Burke
Sammy Wilson
author_sort Nick Wragg (1260240)
collection Figshare
description The widening gap between organ availability and need is resulting in a worldwide crisis, particularly concerning kidney transplantation. Regenerative medicine options are becoming increasingly advanced and are taking advantage of progress in novel manufacturing techniques, including 3D bioprinting, to deliver potentially viable alternatives. Cell-integrated and wearable artificial kidneys aim to create convenient and efficient systems of filtration and restore elements of immunoregulatory function. Whilst preliminary clinical trials demonstrated promise, manufacturing and trial design issues and identification of suitable and sustainable cell sources have shown that more development is required for market progression. Tissue engineering and advances in biomanufacturing techniques offer potential solutions for organ shortages; however, due to the complex kidney structure, previous attempts have fallen short. With the recent development and progression of 3D bioprinting, cell positioning and resolution of material deposition in organ manufacture have never seen greater control. Cell sources for constructing kidney building blocks and populating both biologic and artificial scaffolds and matrices have been identified, but in vitro culturing and/or differentiation, in addition to maintaining phenotype and viability during and after lengthy and immature manufacturing processes, presents additional problems. For all techniques, significant process barriers, clinical pathway identification for translation of models to humans, scaffold material availability, and long-term biocompatibility need to be addressed prior to clinical realisation.
format Default
Article
id rr-article-9565223
institution Loughborough University
publishDate 2019
record_format Figshare
spelling rr-article-95652232019-05-09T00:00:00Z A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations Nick Wragg (1260240) Liam Burke (7212758) Sammy Wilson (1259568) Mechanical engineering not elsewhere classified untagged Mechanical Engineering not elsewhere classified The widening gap between organ availability and need is resulting in a worldwide crisis, particularly concerning kidney transplantation. Regenerative medicine options are becoming increasingly advanced and are taking advantage of progress in novel manufacturing techniques, including 3D bioprinting, to deliver potentially viable alternatives. Cell-integrated and wearable artificial kidneys aim to create convenient and efficient systems of filtration and restore elements of immunoregulatory function. Whilst preliminary clinical trials demonstrated promise, manufacturing and trial design issues and identification of suitable and sustainable cell sources have shown that more development is required for market progression. Tissue engineering and advances in biomanufacturing techniques offer potential solutions for organ shortages; however, due to the complex kidney structure, previous attempts have fallen short. With the recent development and progression of 3D bioprinting, cell positioning and resolution of material deposition in organ manufacture have never seen greater control. Cell sources for constructing kidney building blocks and populating both biologic and artificial scaffolds and matrices have been identified, but in vitro culturing and/or differentiation, in addition to maintaining phenotype and viability during and after lengthy and immature manufacturing processes, presents additional problems. For all techniques, significant process barriers, clinical pathway identification for translation of models to humans, scaffold material availability, and long-term biocompatibility need to be addressed prior to clinical realisation. 2019-05-09T00:00:00Z Text Journal contribution 2134/37750 https://figshare.com/articles/journal_contribution/A_critical_review_of_current_progress_in_3D_kidney_biomanufacturing_advances_challenges_and_recommendations/9565223 CC BY 4.0
spellingShingle Mechanical engineering not elsewhere classified
untagged
Mechanical Engineering not elsewhere classified
Nick Wragg
Liam Burke
Sammy Wilson
A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations
title A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations
title_full A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations
title_fullStr A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations
title_full_unstemmed A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations
title_short A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations
title_sort critical review of current progress in 3d kidney biomanufacturing: advances, challenges, and recommendations
topic Mechanical engineering not elsewhere classified
untagged
Mechanical Engineering not elsewhere classified
url https://hdl.handle.net/2134/37750